0001209191-16-115635.txt : 20160426
0001209191-16-115635.hdr.sgml : 20160426
20160426120805
ACCESSION NUMBER: 0001209191-16-115635
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150204
FILED AS OF DATE: 20160426
DATE AS OF CHANGE: 20160426
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-313-9650
MAIL ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cagle Gerald D.
CENTRAL INDEX KEY: 0001589991
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 161591048
MAIL ADDRESS:
STREET 1: 135 U.S. HIGHWAY 206
STREET 2: SUITE 15
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-02-04
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001589991
Cagle Gerald D.
C/O AERIE PHARMACEUTICALS, INC.,
2030 MAIN STREET, SUITE 1500
IRVINE
CA
92614
1
0
0
0
Common Stock
2015-02-04
4
P
0
500
25.60
A
4054
D
Common Stock
2015-02-05
4
P
0
500
24.54
A
4554
D
Common Stock
2015-08-10
4
P
0
100
16.31
A
4654
D
Common Stock
2015-08-10
4
P
0
100
16.345
A
4754
D
Common Stock
2015-08-10
4
P
0
100
16.35
A
4854
D
Common Stock
2015-08-10
4
P
0
846
16.39
A
5700
D
Common Stock
2015-08-12
4
P
0
500
15.4585
A
6200
D
Common Stock
2015-08-28
4
P
0
1524
16.60
A
7724
D
Common Stock
2015-08-28
4
P
0
476
16.5999
A
8200
D
This Form 4 reports delinquent transactions that would have been reportable on February 6, 2015, August 12, 2015 and September 1, 2015.
/s/ Richard J. Rubino, Attorney-in-Fact for Gerald D. Cagle
2016-04-26